Thomas Jaecklin

1.4k total citations
25 papers, 863 citations indexed

About

Thomas Jaecklin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Thomas Jaecklin has authored 25 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 6 papers in Oncology. Recurrent topics in Thomas Jaecklin's work include Respiratory Support and Mechanisms (7 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Thomas Jaecklin is often cited by papers focused on Respiratory Support and Mechanisms (7 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Thomas Jaecklin collaborates with scholars based in United States, Switzerland and France. Thomas Jaecklin's co-authors include Pavel Dulguerov, Roland Giger, Harrison G. Pope, Keyvan Nicoucar, Peter C. Rimensberger, Brian P. Kavanagh, Gail Otulakowski, Vincent des Portes, Jeannie Visootsak and K. Rérat and has published in prestigious journals such as The Lancet, Hepatology and Journal of Applied Physiology.

In The Last Decade

Thomas Jaecklin

25 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Jaecklin United States 13 405 359 161 128 119 25 863
Renato Pietroletti Italy 14 615 1.5× 57 0.2× 35 0.2× 85 0.7× 42 0.4× 66 894
Patricia Pastor Spain 13 210 0.5× 139 0.4× 21 0.1× 29 0.2× 69 0.6× 29 892
Manshi Li United States 15 114 0.3× 158 0.4× 24 0.1× 52 0.4× 26 0.2× 46 641
Urszula Łebkowska Poland 13 128 0.3× 123 0.3× 59 0.4× 56 0.4× 51 0.4× 61 600
Simon S. Rabinowitz United States 13 266 0.7× 95 0.3× 51 0.3× 60 0.5× 189 1.6× 48 753
Howard R. Mertz United States 9 272 0.7× 108 0.3× 14 0.1× 34 0.3× 49 0.4× 16 669
David D. Stephenson United States 13 172 0.4× 25 0.1× 317 2.0× 63 0.5× 62 0.5× 35 743
Alex Fich Israel 16 297 0.7× 75 0.2× 85 0.5× 10 0.1× 37 0.3× 32 618
Neil Kramer United States 14 59 0.1× 124 0.3× 48 0.3× 15 0.1× 43 0.4× 35 655
Mustafa Cengiz Türkiye 13 146 0.4× 66 0.2× 24 0.1× 23 0.2× 49 0.4× 38 560

Countries citing papers authored by Thomas Jaecklin

Since Specialization
Citations

This map shows the geographic impact of Thomas Jaecklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jaecklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jaecklin more than expected).

Fields of papers citing papers by Thomas Jaecklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Jaecklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jaecklin. The network helps show where Thomas Jaecklin may publish in the future.

Co-authorship network of co-authors of Thomas Jaecklin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Jaecklin. A scholar is included among the top collaborators of Thomas Jaecklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Jaecklin. Thomas Jaecklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowlus, Christopher L., Bertus Eksteen, Angela Cheung, et al.. (2023). Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology Communications. 7(6). 22 indexed citations
2.
Loomes, Kathleen M., Robert H. Squires, Déirdre Kelly, et al.. (2022). Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study. Hepatology Communications. 6(9). 2379–2390. 39 indexed citations
3.
Gonzalès, Emmanuel, Winita Hardikar, Michael Stormon, et al.. (2021). Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. The Lancet. 398(10311). 1581–1592. 103 indexed citations
4.
5.
Gonzalès, Emmanuel, Winita Hardikar, Michael Stormon, et al.. (2020). Maralixibat Treatment Significantly Reduces Pruritus and Serum Bile Acids in Patients with Alagille Syndrome: Results from a Randomized Phase II Study with 4 Years of Follow-Up. SSRN Electronic Journal. 3 indexed citations
6.
Gonzalès, Emmanuel, Ekkehard Sturm, Michael Stormon, et al.. (2019). DURABILITY OF TREATMENT EFFECT WITH LONG-TERM MARALIXIBAT IN CHILDREN WITH ALAGILLE SYNDROME: 4-YEAR SAFETY AND EFFICACY RESULTS FROM THE ICONIC STUDY. Hepatology. 70(6). 1 indexed citations
7.
Burch, Michael, Thomas Severin, Thomas Jaecklin, et al.. (2019). Systematic literature review on the economic, humanistic, and societal burden of heart failure in children and adolescents. Expert Review of Pharmacoeconomics & Outcomes Research. 19(4). 397–408. 3 indexed citations
8.
Shaddy, Robert E., Aneesh Thomas George, Thomas Jaecklin, et al.. (2017). Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents. Pediatric Cardiology. 39(3). 415–436. 65 indexed citations
9.
Berry‐Kravis, Elizabeth, Vincent des Portes, Randi J. Hagerman, et al.. (2016). Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Science Translational Medicine. 8(321). 321ra5–321ra5. 185 indexed citations
10.
Jaecklin, Thomas, Julia Duerr, Hailu Huang, et al.. (2014). Lung arginase expression and activity is increased in cystic fibrosis mouse models. Journal of Applied Physiology. 117(3). 284–288. 12 indexed citations
11.
Grasemann, Hartmut, Thomas Jaecklin, Anne Mehl, et al.. (2014). Multitracer Stable Isotope Quantification of Arginase and Nitric Oxide Synthase Activity in a Mouse Model of Pseudomonas Lung Infection. Mediators of Inflammation. 2014. 1–7. 7 indexed citations
12.
Vignaux, Laurence, Serge Grazioli, Lise Piquilloud, et al.. (2013). Patient–Ventilator Asynchrony During Noninvasive Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist in Infants and Children. Pediatric Critical Care Medicine. 14(8). e357–e364. 39 indexed citations
13.
Vignaux, Laurence, Serge Grazioli, Lise Piquilloud, et al.. (2013). Optimizing Patient-Ventilator Synchrony During Invasive Ventilator Assist in Children and Infants Remains a Difficult Task*. Pediatric Critical Care Medicine. 14(7). e316–e325. 42 indexed citations
14.
Jaecklin, Thomas, Doreen Engelberts, Gail Otulakowski, et al.. (2011). Lung-derived soluble mediators are pathogenic in ventilator-induced lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 300(4). L648–L658. 37 indexed citations
15.
Vignaux, Laurence, Serge Grazioli, Thomas Jaecklin, et al.. (2011). Patient-Ventilator Asynchrony During Mechanical Invasive Assisted Ventilation In Children: Preliminary Results. A1696–A1696. 2 indexed citations
16.
Jaecklin, Thomas, Gail Otulakowski, & Brian P. Kavanagh. (2010). Do soluble mediators cause ventilator-induced lung injury and multi-organ failure?. Intensive Care Medicine. 36(5). 750–757. 23 indexed citations
17.
Nicoucar, Keyvan, Roland Giger, Harrison G. Pope, Thomas Jaecklin, & Pavel Dulguerov. (2009). Management of congenital fourth branchial arch anomalies: a review and analysis of published cases. Journal of Pediatric Surgery. 44(7). 1432–1439. 146 indexed citations
18.
Nicoucar, Keyvan, Roland Giger, Thomas Jaecklin, Harrison G. Pope, & Pavel Dulguerov. (2009). Management of Congenital Third Branchial Arch Anomalies: A Systematic Review. Otolaryngology. 142(1). 21–28. 74 indexed citations
19.
Jaecklin, Thomas, Denis R. Morel, & Peter C. Rimensberger. (2006). Volume-targeted modes of modern neonatal ventilators: how stable is the delivered tidal volume?. Intensive Care Medicine. 33(2). 326–335. 25 indexed citations
20.
Jaecklin, Thomas, Peter Rohner, Véronique Jacomo, Kurt Schmidheiny, & Alain Gervaix. (2005). Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland. European Journal of Pediatrics. 165(1). 3–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renato Pietroletti Breakdown of academic impact, for papers by Patricia Pastor Breakdown of academic impact, for papers by Manshi Li Breakdown of academic impact, for papers by Urszula Łebkowska Breakdown of academic impact, for papers by Simon S. Rabinowitz Breakdown of academic impact, for papers by Howard R. Mertz Breakdown of academic impact, for papers by David D. Stephenson Breakdown of academic impact, for papers by Alex Fich Breakdown of academic impact, for papers by Neil Kramer Breakdown of academic impact, for papers by Mustafa Cengiz
Rankless by CCL
2026